Stock Trading History of Tananbaum James B

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Tananbaum James B since year 2005. The trader's CIK number is 1162061. At the time of this reporting, Tananbaum James B is the Director of Novavax Inc . (stock ticker symbol NVAX). See this page for all insider trading activities at Novavax Inc .
Note that in the past TANANBAUM JAMES B also reported insider trading activities as an insider of the following companies:

Insider Activities at Novavax Inc (NVAX)
Insider Activities at Jazz Pharmaceuticals Inc (JAZZ)
Insider Activities at Critical Therapeutics Inc (CRTX)
Insider Activities at Vanda Pharmaceuticals Inc. (VNDA)

Stock purchases, sales, and option exercises reported by insider *Tananbaum James B* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2008-07-31	NVAX	Novavax Inc	Purchase	35,181	.00	0
2008-07-21	JAZZ	Jazz Pharmaceuticals Inc	Purchase	190,334	.00	0
2007-06-14	CRTX	Critical Therapeutics Inc	Sale	195,751	2.29	448,680
2007-06-11	CRTX	Critical Therapeutics Inc	Sale	2,400	2.50	6,000
2007-06-12	CRTX	Critical Therapeutics Inc	Sale	60,910	2.38	144,862
2007-06-13	CRTX	Critical Therapeutics Inc	Sale	300,000	2.23	669,120
2007-06-07	CRTX	Critical Therapeutics Inc	Sale	1,000	2.68	2,680
2007-06-08	CRTX	Critical Therapeutics Inc	Sale	288,000	2.50	720,604
2007-06-06	CRTX	Critical Therapeutics Inc	Sale	330,794	2.69	889,339
2007-06-01	CRTX	Critical Therapeutics Inc	Sale	398,894	2.90	1,156,473
2007-06-04	CRTX	Critical Therapeutics Inc	Sale	315,773	2.76	871,786
2007-06-05	CRTX	Critical Therapeutics Inc	Sale	387,500	2.66	1,032,648
2006-12-11	VNDA	Vanda Pharmaceuticals Inc.	Sale	738,591	26.56	19,616,976
2006-12-12	VNDA	Vanda Pharmaceuticals Inc.	Sale	6,878	25.27	173,807

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tananbaum James B (Director of Novavax Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.